Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Numient

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Carbidopa / Levodopa

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis
Objectives Extended-release (ER) carbidopa-levodopa (CD-LD) (IPX066/RYTARY/NUMIENT) produces improvements in “off” time, “on… Expand
Review
2017
Review
2017
Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa–Levodopa
Parkinson’s disease (PD) is a chronic progressive neurological disorder characterized by resting tremor, rigidity, bradykinesia… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Review
2015
Review
2015
Carbidopa/Levodopa ER Capsules (Rytary®, Numient™): A Review in Parkinson’s Disease
A new extended-release (ER) capsule formulation of carbidopa/levodopa (Rytary®, Numient™, IPX066) is available for the treatment… Expand
  • table 1
  • table 2
  • table 3
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE